152 related articles for article (PubMed ID: 8787875)
1. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.
Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
Antimicrob Agents Chemother; 1996 Jan; 40(1):35-9. PubMed ID: 8787875
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
Meyer RD; Draus LL; Pasieczinik KA
Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
[TBL] [Abstract][Full Text] [Related]
3. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
4. New epidemiological data on resistance to netilmicin and other aminoglycosides.
Toscano MA; Minneci M; Salmeri M; Nicoletti G
J Chemother; 1991 Dec; 3(6):352-6. PubMed ID: 1819617
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
6. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
Van der Auwera P
J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
[TBL] [Abstract][Full Text] [Related]
7. A laboratory assessment of the activities of four aminoglycosides.
Schrire L; Robinson RG; Koornhof HJ
S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
9. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
Omri A; Ravaoarinoro M; Poisson M
J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
[TBL] [Abstract][Full Text] [Related]
10. The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.
Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
J Antimicrob Chemother; 1996 May; 37(5):993-8. PubMed ID: 8737149
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the bactericidal action of amikacin, netilmicin and tobramycin in free and liposomal formulation against Pseudomonas aeruginosa.
Omri A; Ravaoarinoro M
Chemotherapy; 1996; 42(3):170-6. PubMed ID: 8983883
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
Zhanel GG; Karlowsky JA; Hoban DJ; Davidson RJ
Chemotherapy; 1991; 37(2):114-21. PubMed ID: 1903340
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane proteins and elastase of Pseudomonas aeruginosa after the postantibiotic effect induced by amikacin.
Hostacká A; Karelová E
Chemotherapy; 1997; 43(2):118-22. PubMed ID: 9084920
[TBL] [Abstract][Full Text] [Related]
14. Invitro comparative evaluation of aminoglycosides at a cancer centre.
Biswas SK; Kelkar RS
Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
[TBL] [Abstract][Full Text] [Related]
15. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Majtán V; Hostacká A
Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
[TBL] [Abstract][Full Text] [Related]
16. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Blaser J
J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863
[TBL] [Abstract][Full Text] [Related]
18. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Hybenová D; Majtán V
Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
[TBL] [Abstract][Full Text] [Related]
19. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
Knothe H; Krcméry V
Chemotherapy; 1979; 25(1):23-9. PubMed ID: 105839
[No Abstract] [Full Text] [Related]
20. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
